Citadel Advisors’s Filana Therapeutics FLNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-13,864
| Closed | -$44.4K | – | 13888 |
|
|
2025
Q3 | $40.3K | Buy |
+13,864
| New | +$31.9K | ﹤0.01% | 12292 |
|
|
2025
Q2 | – | Sell |
-73
| Closed | -$130 | – | 14734 |
|
|
2025
Q1 | $110 | Buy |
+73
| New | +$184 | ﹤0.01% | 14331 |
|
|
2024
Q3 | – | Sell |
-37,137
| Closed | -$855K | – | 15112 |
|
|
2024
Q2 | $459K | Buy |
37,137
+32,835
| +763% | +$692K | ﹤0.01% | 8233 |
|
|
2024
Q1 | $87.3K | Buy |
+4,302
| New | +$99.1K | ﹤0.01% | 11536 |
|
|
2023
Q4 | – | Sell |
-8,798
| Closed | -$186K | – | 15111 |
|
|
2023
Q3 | $146K | Sell |
8,798
-143,107
| -94% | -$2.84M | ﹤0.01% | 10399 |
|
|
2023
Q2 | $3.72M | Buy |
151,905
+13,648
| +10% | +$329K | ﹤0.01% | 4098 |
|
|
2023
Q1 | $3.33M | Buy |
138,257
+106,023
| +329% | +$2.94M | ﹤0.01% | 4469 |
|
|
2022
Q4 | $952K | Buy |
+32,234
| New | +$1.16M | ﹤0.01% | 6914 |
|
|
2022
Q3 | – | Sell |
-9,449
| Closed | -$255K | – | 13488 |
|
|
2022
Q2 | $266K | Buy |
+9,449
| New | +$239K | ﹤0.01% | 10090 |
|
|
2021
Q4 | – | Sell |
-21,356
| Closed | -$1.12M | – | 14636 |
|
|
2021
Q3 | $1.33M | Sell |
21,356
-290,182
| -93% | -$24.2M | ﹤0.01% | 7409 |
|
|
2021
Q2 | $26.6M | Buy |
311,538
+63,809
| +26% | +$3.42M | 0.01% | 1739 |
|
|
2021
Q1 | $11.1M | Buy |
247,729
+182,351
| +279% | +$7.17M | ﹤0.01% | 2820 |
|
|
2020
Q4 | $446K | Buy |
65,378
+36,989
| +130% | +$330K | ﹤0.01% | 8363 |
|
|
2020
Q3 | $327K | Sell |
28,389
-94,660
| -77% | -$427K | ﹤0.01% | 7989 |
|
|
2020
Q2 | $379K | Buy |
123,049
+105,276
| +592% | +$477K | ﹤0.01% | 7534 |
|
|
2020
Q1 | $73K | Buy |
+17,773
| New | +$118K | ﹤0.01% | 8835 |
|
|
2019
Q2 | – | Sell |
-20,731
| Closed | -$27K | – | 9757 |
|
|
2019
Q1 | $27K | Buy |
+20,731
| New | +$23.8K | ﹤0.01% | 9014 |
|
|
2017
Q2 | – | Sell |
-3,808
| Closed | -$24K | – | 7988 |
|
|
2017
Q1 | $24K | Buy |
+3,808
| New | +$17.3K | ﹤0.01% | 7209 |
|
|
2015
Q4 | – | Sell |
-1,298
| Closed | -$17K | – | 9126 |
|
|
2015
Q3 | $17K | Buy |
1,298
+879
| +210% | +$11.1K | ﹤0.01% | 8265 |
|
|
2015
Q2 | $5K | Buy |
+419
| New | +$5.74K | ﹤0.01% | 8542 |
|
|
2015
Q1 | – | Sell |
-4,159
| Closed | -$59K | – | 8807 |
|
|
2014
Q4 | $59K | Buy |
+4,159
| New | +$72K | ﹤0.01% | 7075 |
|
|
2014
Q3 | – | Sell |
-672
| Closed | -$27K | – | 8360 |
|
|
2014
Q2 | $27K | Sell |
672
-11,794
| -95% | -$436K | ﹤0.01% | 7142 |
|
|
2014
Q1 | $480K | Buy |
12,466
+8,898
| +249% | +$314K | ﹤0.01% | 4391 |
|
|
2013
Q4 | $121K | Sell |
3,568
-9,039
| -72% | -$240K | ﹤0.01% | 5457 |
|
|
2013
Q3 | $240K | Sell |
12,607
-14,069
| -53% | -$246K | ﹤0.01% | 4586 |
|
|
2013
Q2 | $413K | Buy |
+26,676
| New | +$564K | ﹤0.01% | 4018 |
|
Other funds holding FLNA
VCM
GC
Citadel Advisors's FLNA Position: Q4 2025 in Review
Citadel Advisors sold out of Filana Therapeutics (FLNA) in Q4 2025, closing a stake of 13,864 shares — an estimated $44.4K sold.
Citadel Advisors first reported a position in FLNA in Q2 2013 and held it in 26 quarters. The position peaked at $26.6M in Q2 2021. 107 funds tracked by Wall St. Rank hold FLNA as of Q4 2025.
- Citadel Advisors reported no remaining Filana Therapeutics position as of Q4 2025 after selling out during the quarter.
- Citadel Advisors sold 13,864 Filana Therapeutics shares in Q4 2025, an estimated $44.4K.
- Citadel Advisors first reported a position in Filana Therapeutics in Q2 2013 and held it in 26 quarters.
- Citadel Advisors's Filana Therapeutics position peaked at $26.6M in Q2 2021.
- 107 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2025.
Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.